SCHEMBL1763822

SCHEMBL1763822

CC(C)(C)OC(=O)NC(=N)NC(=O)c1ccc(C2CCNCC2)c(C(F)(F)F)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A3 Q01959 3/20 0.42
ADRA1D P25100 2/20 0.42
HTR2C P28335 2/20 0.39
SLC9A1 P19634 9/20 0.39
CYP2C9 P11712 5/20 0.38
CYP2C19 P33261 4/20 0.38
CYP3A4 P08684 4/20 0.38
KCNH2 Q12809 1/20 0.38
HTR2A P28223 1/20 0.37
SLC9A2 Q9UBY0 1/20 0.37
DDR1 Q08345 2/20 0.37
TAS1R3 Q7RTX0 2/20 0.36
TAS1R1 Q7RTX1 2/20 0.36
TAS1R2 Q8TE23 2/20 0.36
HTR1A P08908 1/20 0.35
SLC6A2 P23975 1/20 0.35
SLC6A4 P31645 1/20 0.35
CYP2D6 P10635 1/20 0.35
RBP4 P02753 1/20 0.35
S1PR1 P21453 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1764034 0.81 SLC9A1 (0.46) SLC6A3ADRA1DHTR2CSLC9A1CYP2C9
SCHEMBL1763854 0.76 RBP4 (0.55) SLC6A3ADRA1DHTR2CSLC9A1CYP2C9
SCHEMBL1763177 0.72 SLC9A1 (0.61) SLC6A3ADRA1DSLC9A1CYP2C9CYP2C19
SCHEMBL31701697 0.72 SLC9A1 (0.54) SLC6A3ADRA1DHTR2CSLC9A1CYP2C9
SCHEMBL1764032 0.71 HTR1A (0.38) SLC6A3HTR2CHTR1ASLC6A2SLC6A4
Hydrochloric Acid SCHEMBL8506226 0.70 SLC9A1 (0.48) SLC6A3ADRA1DSLC9A1CYP2C9CYP2C19
SCHEMBL1763870 0.70 CHRNB2 (0.51) SLC6A3ADRA1DHTR2CSLC9A1CYP2C9
SCHEMBL25894474 0.69 CA12 (0.44)
SCHEMBL1763934 0.69 SLC9A1 (0.54) SLC9A1CYP2C9CYP2C19CYP3A4KCNH2
SCHEMBL1763871 0.69 ITGB3 (0.38) SLC6A3SLC9A1HTR1ASLC6A2SLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110118262-A1 Pyrrolidinyl and Piperidinyl Compounds Useful as NHE-1 Inhibitiors BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2011-05-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110118262-A1 Pyrrolidinyl and Piperidinyl Compounds Useful as NHE-1 Inhibitiors NHERF1, SLC9A1, SLC9A5 SLC6A3 98/4885ADRA1D 1467/4885HTR2C 983/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.